World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   317 records for 98 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10
Recruitment statusMain ID Public TitleDate of Registration
RecruitingISRCTN13716228
everyBody – Tailored online health promotion and eating disorder prevention for women at different risk stages
26/02/2016
RecruitingNCT02699736
Clinical and Virological Outcome of European Patients Infected With HIV
19/01/2016
RecruitingNCT02607878
Automated Pupillometry for Coma Prognostication After Cardiac Arrest
02/11/2015
RecruitingNCT02588144
Combined Stimulation of STN and SNr for Resistant Freezing of Gait in Parkinson's Disease
24/10/2015
AuthorisedEUCTR2015-001088-38-FI
A study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2015-001088-38-ESA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.05/11/2015
AuthorisedEUCTR2015-001088-38-DEA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.23/09/2015
AuthorisedEUCTR2015-001088-38-CZA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.12/10/2015
AuthorisedEUCTR2015-001088-38-DKA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.03/11/2015
RecruitingNCT02626455Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)03/11/2015
AuthorisedEUCTR2015-001088-38-GBA study investigating copanlisib in combination with standard treatment versus standard treatment alone in order to see if copanlisib improves the response to standard treatment in patients with relapsed indolent non-Hodgkin's lymphoma.12/11/2015
21/09/2015
RecruitingNCT02552940
An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical Practice
16/09/2015
RecruitingDRKS00007912
Non-interventional study on Edoxaban treatment in routine clinical practice for patients with non valvular atrial fibrillation
30/07/2015
Not recruitingNCT02495051
Esophageal Atresia: Metaplasia, Barrett
22/06/2015
Not recruitingNCT02525562
Stryker NTX Registry Scorpio NRG (Re-"Energize"), Triathlon Total Knee, Triathlon Partial Knee Resurfacing (PKR) With X3 Polyethylene Insert
11/06/2015
RecruitingNCT02367040
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2013-003893-29-LTA study investigating the efficacy and safety of copanlisib in combination with rituximab in patients with relapsed indolent B-cell non-Hodgkin's lymphoma.03/04/2015
AuthorisedEUCTR2013-003893-29-IEA study investigating the efficacy and safety of copanlisib in combination with rituximab in patients with relapsed indolent B-cell non-Hodgkin's lymphoma.05/03/2015
AuthorisedEUCTR2013-003893-29-ESA study investigating the efficacy and safety of copanlisib in combination with rituximab in patients with relapsed indolent B-cell non-Hodgkin's lymphoma.27/03/2015
AuthorisedEUCTR2013-003893-29-LUA study investigating the efficacy and safety of copanlisib in combination with rituximab in patients with relapsed indolent B-cell non-Hodgkin's lymphoma.08/01/2016
AuthorisedEUCTR2013-003893-29-BGA study investigating the efficacy and safety of copanlisib in combination with rituximab in patients with relapsed indolent B-cell non-Hodgkin's lymphoma.01/10/2015
Not RecruitingEUCTR2013-003893-29-DKA study investigating the efficacy and safety of copanlisib in combination with rituximab in patients with relapsed indolent B-cell non-Hodgkin's lymphoma.15/06/2015
AuthorisedEUCTR2013-003893-29-GRA study investigating the efficacy and safety of copanlisib in combination with rituximab in patients with relapsed indolent B-cell non-Hodgkin's lymphoma.17/02/2016
AuthorisedEUCTR2013-003893-29-DEA study investigating the efficacy and safety of copanlisib in combination with rituximab in patients with relapsed indolent B-cell non-Hodgkin's lymphoma.20/03/2015
AuthorisedEUCTR2013-003893-29-ATA study investigating the efficacy and safety of copanlisib in combination with rituximab in patients with relapsed indolent B-cell non-Hodgkin's lymphoma.22/05/2015
AuthorisedEUCTR2013-003893-29-HUA study investigating the efficacy and safety of copanlisib in combination with rituximab in patients with relapsed indolent B-cell non-Hodgkin's lymphoma.10/04/2015
AuthorisedEUCTR2013-003893-29-PTA study investigating the efficacy and safety of copanlisib in combination with rituximab in patients with relapsed indolent B-cell non-Hodgkin's lymphoma.17/03/2015
12/02/2015
    
1 2 3 4 5 6 7 8 9 10
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history